We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

Figure 2

Figure 2. Mechanisms of p53-mediated apoptosis. From: Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease.

The transcription factor p53 regulates the induction of apoptosis by regulating BAX, PUMA and APAF-1 expression. The permeability of the mitochondria and subsequent release of cytochrome C is regulated by a balance between antiapoptotic (i.e., BCL-2) and proapoptotic (i.e., BAX) factors. The increase of the proapoptotic BAX and its effector molecule, PUMA, in response to p53, interacts with and overcomes the antiapoptotic BCL-2, resulting in the release of mitochondrial cytochrome C. Cytochrome C, together with ATP and APAF-1, acts to activate caspase 9 in the activation of apoptosis through the intrinsic pathway. APAF: Apoptotic protease-activating factor; BAX: BCL-2-associated X protein; BCL-2: B-cell lymphoma-2 protein; CHIP: Carboxyl terminus of Hsp70-interacting protein; MDM: Murine double minute; PUMA: p53-upregulated modulator of apoptosis.

Monte S Willis, et al. Future Cardiol. ;4(1):65-75.
Figure 1

Figure 1. Overview of the ubiquitin-proteasome system. From: Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease.

The degradation of proteins via the ubiquitin-proteasome system is dependent on the sequential addition of ubiquitin molecules on targeted protein substrates. (A) Free ubiquitin is activated by the E1 enzyme and transferred to an E2 enzyme. E3 ubiquitin ligases mediate the transfer of the ubiquitin molecule from the E2 to the substrate protein, a process that is repeated, resulting in polyubiquitin chain formation on the protein substrate. Polyubiquitin chains are subsequently recognized by the 26S proteasome, resulting in cleavage of the protein substrate into small peptides and the release of ubiquitin molecules. (B) Homologous polyubiquitin chains formed via linkages at lysine-48 of the presiding ubiquitin molecule result in a chain conformation that is recognized by the 26S proteasome. Conversely, polyubiquitin chains coupled via lysine-63 linkages yield chain conformations that are not recognized by the 26S proteasome; rather, these linkages alter the function of the protein substrate. Lys: Lysine; Ub: Ubiquitin.

Monte S Willis, et al. Future Cardiol. ;4(1):65-75.
Figure 3

Figure 3. Ubiquitin-proteasome system-mediated resulation of the nuclear factor-κB activation pathway. From: Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease.

Activation of the multimeric IKK mediates the phosphorylation of IκB. The modified IκB is then recognized by the SCF-βTrCP E3 ubiquitin ligase and targeted for degradation via the ubiquitin-proteasome system, liberating the p50/p65 nuclear factor (NF)-κB dimer. This results in the exposure of a nuclear localization signal on p50/p65, previously obscured by IκB, promoting the nuclear translocation of p50/p65 and the subsequent activation of the NF-κB transcriptional program. Multiple pathways pertinent to cardiac hypertrophy and failure are activated by NF-κB-mediated transcription, such as cell adhesion, apoptosis, inflammation and immune-response signaling molecules. AGT: Angiotensinogen; CBF: Complement factor B; IAP: Inhibitor of apoptosis protein; ICAM: Intercellular adhesion molecule; IκB: Inhibitor of κB; IKK: IκB kinase complex; P: Phosphate; SAA: Serum amyloid A; SCF-βTrCP: Skip-Cullin-F box β-transducin repeat-containing protein; Ub: Ubiquitin; VCAM: Vascular cell adhesion molecule.
Figure adapted from [65,66].

Monte S Willis, et al. Future Cardiol. ;4(1):65-75.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk